General Information
GSK57 Harmony
A randomized, double-blind, placebo and active controlled, parallel group, multi-center study to determine the efficacy and safety of albiglutide administered in combination with metformin plus glimepiride and placebo with metformin plus glimepiride, and pioglitazone in subjects with type 2 diabetes mellitus
| Protocol | GLP112757 |
|---|---|
| Identifier | GLP112757 |
| UID | e505c610-13a4-4d5f-bff5-a40559a408d6 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2009 |
| NCT Number | - |
| Created | 2010-05-21 16:00 |
| Last Updated | 2010-05-21 16:00 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | 2009-08-17 | No |
| Site Initiation Mtg. | 2009-02-04 | No |
| PI Meeting Start | 2009-03-04 | No |
| PI Meeting End | 2009-03-06 | No |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2013-05-15 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Unger, Jeffrey | JUnger | No |
| Recruiter | - | No | |
| Coordinator | Pereira, Cynthia | CPereira | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | GlaxoSmithKline |
|---|---|
| Division | GlaxoSmithKline |
| Team | GlaxoSmithKline |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | IRB ID No. 24255/301 |
|---|---|
| CRO | PPD Investigator Services, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
